Enzo Biochem, Inc.
Sphingosine pathway modulating compounds for the treatment of cancers

Abstract:

The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.